Synthesis and biological activity of Akt/PI3K inhibitors

被引：15
|
作者：
Redaelli, C. [1 ]
Granucci, F. [1 ]
De Gioia, L. [1 ]
Cipolla, L. [1 ]
机构：
[1] Univ Milan, Dept Biosci & Biotechnol, I-20126 Milan, Italy
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2006年 / 6卷 / 10期
关键词：
kinases; Akt; PI3K; cancer; kinase inhibitors; allosteric inhibitors; phosphatidylinositol; phosphatidylinositol analogues;
D O I：
10.2174/138955706778560139
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Phosphatidylinositol 3-kinase (PI3K) and serine/threonine protein kinase B (PKB or Akt) pathways regulate important cellular processes and are related to a number of human pathologies, such as cancer. The development of kinase inhibitors, with particular attention to small molecule analogues of natural phosphoinositides for pathway interruption and therapeutic applications will be reviewed.
引用
收藏
页码：1127 / 1136
页数：10
相关论文
共 50 条
  • [1] Synthesis and Biological Activity of Novel PI3K/mTOR Inhibitors
    Wang Lei
    Zheng Guojun
    Ji Qi
    Chen Bo
    Gong Longlong
    Gao Congmin
    Du Zhenjian
    Zhang Xingmin
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2017, 38 (09): : 1590 - 1595
  • [2] The development of inhibitors of PI3K and Akt
    Dennis, PA
    ANNALS OF ONCOLOGY, 2006, 17 : 24 - 24
  • [3] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [4] Predictive and pharmacodynamic (PD) markers of PI3K pathway inhibitors: focus on PI3K, AKT and mTOR inhibitors
    Tabernero, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S6 - S6
  • [5] PI3K/Akt/mTOR inhibitors in breast cancer
    Joycelyn JX Lee
    Kiley Loh
    Yoon-Sim Yap
    Cancer Biology & Medicine, 2015, (04) : 342 - 354
  • [6] PI3K/Akt/mTOR inhibitors in breast cancer
    Lee, Joycelyn J. X.
    Loh, Kiley
    Yap, Yoon-Sim
    CANCER BIOLOGY & MEDICINE, 2015, 12 (04) : 342 - 354
  • [7] Design, Synthesis, and Biological Activity of Pyridopyrimidine Scaffolds as Novel PI3K/mTOR Dual Inhibitors
    Saurat, Thibault
    Buron, Frederic
    Rodrigues, Nuno
    de Tauzia, Marie-Ludivine
    Colliandre, Lionel
    Bourg, Stephane
    Bonnet, Pascal
    Guillaumet, Gerald
    Akssira, Mohamed
    Corlu, Anne
    Guillouzo, Christiane
    Berthier, Pauline
    Rio, Pascale
    Jourdan, Marie-Lise
    Benedetti, Helene
    Routier, Sylvain
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (03) : 613 - 631
  • [8] PI3K/AKT/mTOR Inhibitors In Ovarian Cancer
    Mazzoletti, M.
    Broggini, M.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (36) : 4433 - 4447
  • [9] PI3K/Akt/mTOR inhibitors in breast cancer
    Joycelyn JX Lee
    Kiley Loh
    Yoon-Sim Yap
    Cancer Biology & Medicine, 2015, 12 (04) : 342 - 354
  • [10] Design,synthesis and biological evaluation of acylhydrazone derivatives as PI3K inhibitors
    Guo-Rui Gao
    Jia-Li Liu
    De-Sheng Mei
    Jian Ding
    Ling-Hua Meng
    Wen-Hu Duan
    ChineseChemicalLetters, 2015, 26 (01) : 118 - 120
12345